Abstract

BackgroundPatients with relapsed and refractory multiple myeloma (RRMM) have a median survival of about 3–6 months.1PurposeThe aim of the study was to analyse efficacy, safety and cost of pomalidomide in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and Safety of Daratumumab Based Regimens for Multiple Myeloma: A Systematic Review and Meta-Analysis
Muhammad Abu Zar ... Faiz Anwer
Blood | VOL. 132
Muhammad Abu Zar, et. al.Muhammad Abu Zar ... Faiz Anwer
29 Nov 2018
PCN78 UTILIZATION AND COSTS ASSOCIATED WITH HOSPITALIZATIONS AMONG ADULTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE US
J Yeaw ... J Richter
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
J Yeaw, et. al.J Yeaw ... J Richter
01 May 2020
Burden of Hospitalization before and after a Disease Progression Following Triple-Class Exposure in Patients with Relapsed and Refractory Multiple Myeloma
Jennifer S Harper ... Sundar Jagannath
Blood | VOL. 140
Jennifer S Harper, et. al.Jennifer S Harper ... Sundar Jagannath
15 Nov 2022
Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma.
Pauline Gueneau ... Marie‐Lorraine Chretien
Scandinavian Journal of Haematology | VOL. 100
Pauline Gueneau, et. al.Pauline Gueneau ... Marie‐Lorraine Chretien
06 Mar 2018
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
Tien Thuy Ngo ... Charis Lau
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Tien Thuy Ngo, et. al.Tien Thuy Ngo ... Charis Lau
13 Jul 2024
View more papers